MARC, a novel modular chimeric antigen receptor, improves T cell-based cancer immunotherapies by preventing early T cell exhaustion and enhancing persistence by Jean-Sebastien Delisle, Susan Moore, Etienne Gagnon, Margaux Tual, Angélique Bellemare-Pelletier, Delphine Guipouy, Negar Farzam-Kia, Leila Jafarzadeh, Jordan Quenneville, Benoit Barrette, Marc K Saba-El-Leil

Get full text